Have you been diagnosed with migraine? Are you currently pregnant? Have you taken Aimovig® (erenumab-aooe) shortly before or during pregnancy? If so, you may be able to take part in a United States pregnancy registry.
This registry has been created to help doctors better understand if Aimovig has any effect on a woman’s pregnancy, delivery, or baby. However, you do not have to have taken Aimovig to participate.
If you are currently pregnant and taking Aimovig® (erenumab-aooe), contact your healthcare provider. They will decide if you should stop taking Aimovig®.Get more info on the registry
Ask your healthcare provider to help you complete the contact form.
Many pregnant women take medication during pregnancy. Pregnancy registries are studies that follow women who take medication knowingly during pregnancy or before they knew they were pregnant. These studies are a chance to gather vital information about the effects of drugs or treatments on pregnancies and newborns’ health.
Pregnancy registries are the primary way healthcare providers can learn about important safety information.
By enrolling in a pregnancy registry, you can help improve safety information for medicines, which enables informed decision-making by healthcare providers and pregnant women in the future.
By clicking through the website, we understand this means you have accepted our cookies.